|

Valganciclovir (Valcyte) Clinical Trials

1 actively recruiting trial

Top Sponsors

  • National Taiwan University Hospital1

Indications

  • Antiviral Prophylaxis1
  • EBV Infection1
  • Kidney Transplantation, Cytomegalovirus Infections1
  • Cancer1

Other1 trial

Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.